ATP-degrading ENPP1 is required for survival (or persistence) of long-lived plasma cellsHongsheng Wang, Herbert C. Morse, Solomon Conteh et al.|Scientific Reports|2017Cited by 29
Brentuximab Vedotin in Frontline Therapy of Hodgkin Lymphoma in Patients with Significant Comorbidities Ineligible for Standard Chemotherapy (SGN35-015 Part E)Christopher A. Yasenchak, J. Thaddeus Beck, Rodolfo Bordoni et al.|Blood|2023Cited by 1